人工智能在心脏瓣膜疾病中的应用：诊断、创新与治疗。一篇最新综述。
Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review.
作者信息
Bamford Paul, Abdelrahman Amr, Malkin Christopher J, Cunnington Michael S, Blackman Daniel J, Ali Noman
机构信息
Interventional Fellow.
Interventional Cardiologist.
出版信息
Br J Cardiol. 2024 Aug 6;31(3):031. doi: 10.5837/bjc.2024.031. eCollection 2024.
Abstract
In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials. AI can help to guide the treatment of patients with valvular heart disease, by aiding in optimal device selection for transcatheter valvular interventions and, potentially, predicting the risk of specific complications. This review article explores the various potential applications of AI in the diagnosis and treatment of valvular heart disease in more detail.
摘要
近年来，人工智能（AI）已被用于提高心脏瓣膜病诊断和治疗的精准度。它有能力识别心脏瓣膜病患者并进行风险分层，且有望通过更短、更安全和更有效的临床试验推动新治疗方法的创新。人工智能可以辅助选择经导管瓣膜介入治疗的最佳器械，并有可能预测特定并发症的风险，从而帮助指导心脏瓣膜病患者的治疗。这篇综述文章更详细地探讨了人工智能在心脏瓣膜病诊断和治疗中的各种潜在应用。
相似文献
1
Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review.人工智能在心脏瓣膜疾病中的应用：诊断、创新与治疗。一篇最新综述。
Br J Cardiol. 2024 Aug 6;31(3):031. doi: 10.5837/bjc.2024.031. eCollection 2024.
2
Artificial intelligence for the echocardiographic assessment of valvular heart disease.人工智能在心脏瓣膜病超声心动图评估中的应用。
Heart. 2022 Sep 26;108(20):1592-1599. doi: 10.1136/heartjnl-2021-319725.
3
AI-based prediction of left bundle branch block risk post-TAVI using pre-implantation clinical parameters.使用植入前临床参数基于人工智能预测经导管主动脉瓣置换术后左束支传导阻滞风险
Future Cardiol. 2025 Jun;21(7):489-494. doi: 10.1080/14796678.2025.2498866. Epub 2025 Apr 29.
4
Narrative review of the role of artificial intelligence to improve aortic valve disease management.人工智能在改善主动脉瓣疾病管理中作用的叙述性综述。
J Thorac Dis. 2021 Jan;13(1):396-404. doi: 10.21037/jtd-20-1837.
5
Transcatheter Treatment of Valvular Heart Disease: A Review.经导管瓣膜病治疗：综述。
JAMA. 2021 Jun 22;325(24):2480-2494. doi: 10.1001/jama.2021.2133.
6
Artificial intelligence and automation in valvular heart diseases.人工智能和自动化在心脏瓣膜疾病中的应用。
Cardiol J. 2020;27(4):404-420. doi: 10.5603/CJ.a2020.0087. Epub 2020 Jun 22.
7
MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art.用于二尖瓣反流的MitraClip和用于严重主动脉瓣狭窄的经导管主动脉瓣植入术：最新技术。
Postepy Kardiol Interwencyjnej. 2021 Jun;17(2):155-162. doi: 10.5114/aic.2021.107493. Epub 2021 Jul 9.
8
Antithrombotic therapy after transcatheter aortic valve implantation.经导管主动脉瓣植入术后的抗血栓治疗。
Expert Rev Med Devices. 2022 Jun;19(6):499-513. doi: 10.1080/17434440.2022.2106853. Epub 2022 Aug 7.
9
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis.威尔士专科服务采购案例研究：经导管主动脉瓣置换术治疗重度主动脉瓣狭窄
Appl Health Econ Health Policy. 2022 Jul;20(4):487-499. doi: 10.1007/s40258-021-00692-y. Epub 2022 Feb 25.
10
Harnessing the power of artificial intelligence in predicting all-cause mortality in transcatheter aortic valve replacement: a systematic review and meta-analysis.利用人工智能预测经导管主动脉瓣置换术全因死亡率：一项系统评价和荟萃分析。
Front Cardiovasc Med. 2024 May 31;11:1343210. doi: 10.3389/fcvm.2024.1343210. eCollection 2024.
引用本文的文献
1
Contemporary Clinical Treatment Options and Outcomes of Aortic Valve Disease: Integrating Modern Insights into a Cohesive Therapeutic Paradigm.主动脉瓣疾病的当代临床治疗选择与结果：将现代见解融入连贯的治疗模式。
J Cardiovasc Dev Dis. 2025 Jun 12;12(6):223. doi: 10.3390/jcdd12060223.
本文引用的文献
1
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison.美国心脏病学会/美国心脏协会与欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南：JACC 指南比较。
J Am Coll Cardiol. 2023 Aug 22;82(8):721-734. doi: 10.1016/j.jacc.2023.05.061.
2
A systematic review of cardiac clinical trials.一项关于心脏临床试验的系统评价。
Prog Biomed Eng (Bristol). 2023 Jul 1;5(3):032004. doi: 10.1088/2516-1091/acdc71. Epub 2023 Jun 22.
3
Diagnostic accuracy of heart auscultation for detecting valve disease: a systematic review.心脏听诊诊断瓣膜疾病的准确性：系统评价。
BMJ Open. 2023 Mar 24;13(3):e068121. doi: 10.1136/bmjopen-2022-068121.
4
The Future of AI-Enhanced ECG Interpretation for Valvular Heart Disease Screening.人工智能增强型心电图解读在瓣膜性心脏病筛查中的未来
J Am Coll Cardiol. 2022 Aug 9;80(6):627-630. doi: 10.1016/j.jacc.2022.05.034.
5
rECHOmmend: An ECG-Based Machine Learning Approach for Identifying Patients at Increased Risk of Undiagnosed Structural Heart Disease Detectable by Echocardiography.rECHOmmend：一种基于心电图的机器学习方法，用于识别心电图检查可发现但尚未诊断的结构性心脏病风险增加的患者。
Circulation. 2022 Jul 5;146(1):36-47. doi: 10.1161/CIRCULATIONAHA.121.057869. Epub 2022 May 9.
6
Mitral Valve Atlas for Artificial Intelligence Predictions of MitraClip Intervention Outcomes.用于人工智能预测MitraClip介入治疗结果的二尖瓣图谱
Front Cardiovasc Med. 2021 Dec 10;8:759675. doi: 10.3389/fcvm.2021.759675. eCollection 2021.
7
Possible Contexts of Use for In Silico Trials Methodologies: A Consensus-Based Review.计算实验方法的可能应用场景：基于共识的综述。
IEEE J Biomed Health Inform. 2021 Oct;25(10):3977-3982. doi: 10.1109/JBHI.2021.3090469. Epub 2021 Oct 5.
8
Medical robotics-Regulatory, ethical, and legal considerations for increasing levels of autonomy.医疗机器人——自主程度不断提高的监管、伦理和法律考虑因素。
Sci Robot. 2017 Mar 15;2(4). doi: 10.1126/scirobotics.aam8638.
9
Deep Learning-Based Algorithm for Detecting Aortic Stenosis Using Electrocardiography.基于深度学习的心电图主动脉瓣狭窄检测算法。
J Am Heart Assoc. 2020 Apr 7;9(7):e014717. doi: 10.1161/JAHA.119.014717. Epub 2020 Mar 21.
10
Artificial intelligence for detecting mitral regurgitation using electrocardiography.利用心电图检测二尖瓣反流的人工智能技术。
J Electrocardiol. 2020 Mar-Apr;59:151-157. doi: 10.1016/j.jelectrocard.2020.02.008. Epub 2020 Feb 27.
Zotero 插件